|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.750 USD | -0.23% |
|
+8.15% | -6.81% |
| 10:10am | Kyverna Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 11:20 AM | |
| Feb. 24 | Kyverna Therapeutics, Inc. Announces Board and Committee Changes | CI |
Evolution of the Average Target: Kyverna Therapeutics, Inc.
Evolution of the Target Price: Kyverna Therapeutics, Inc.
Changes in Analyst Recommendations: Kyverna Therapeutics, Inc.
8fd99561dbe25165.77t3_aSqd8BrHE6Poa3yuT9us5QEjq26ihPgz83EzNE.3P0hksubKPY9Lzv-yt273mk5w_9p39SNwyaIhq-CvIWnwTvN1pNGtSMkFw~390b059ceb7520bfcb62d03e0e0e4030
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +237.51% | |||||
| +39.48% | |||||
| +43.6% | |||||
| +23.28% | |||||
| +44.96% | |||||
| +36.06% | |||||
| +24.73% | |||||
| +10.33% | |||||
| +16.29% | |||||
| +29.8% | |||||
| Average | +50.61% | |||||
| Weighted average by Cap. | +33.79% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
8.770USD
Average target price
29.60USD
Spread / Average Target
+237.51%
High Price Target
33.00USD
Spread / Highest target
+276.28%
Low Price Target
20.00USD
Spread / Lowest Target
+128.05%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Morgan Stanley | |
| William Blair & Co. | |
| HC Wainwright | |
| UBS | |
| JPMorgan Chase |
SellBuy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
8.770USD
Average target price
29.60USD
Spread / Average Target
+237.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KYTX Stock
- Consensus Kyverna Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
